Navigation Links
OHSU turns innovations into commercial opportunities at record pace
Date:10/23/2007

PORTLAND, Ore. By most measures of an academic medical centers success in fostering innovation and entrepreneurship, fiscal year 2007 was a banner year for Oregon Health & Science University.

  • OHSU researchers disclosed 132 inventions, more than in any previous year in the universitys historyand four times the number in 2000.

  • Five new startup companies based on OHSU discoveries were incorporated during the year, bringing the total to 33 since 2000 and 64 since the early 1970s.

  • Sixty-three nonclinical research agreements totaling $6.7 million, up 37 percent from 4.9 million in the previous year.

  • Income from commercialization of inventions licensed by OHSU nearly doubled to $1.23 million from $719,800 the previous year.

  • The market value of equity OHSU owns in six startups whose shares are publicly traded Novacea, Inc.; Adherex Technologies Inc.; Neurocrine Biosciences, Inc.; Orexigen Therapeutics, Inc.; StemCells, Inc. and Fonix Corporation reached $2.25 million at the end of the fiscal year, up from $1.5 million the previous year.

We are starting to see the payoff from the research facilities made possible by the taxpayers and private donors through the Oregon Opportunity and from the growing aggregation of world-class researchers who have been attracted to OHSU in recent years because of the critical mass they see developing here, said Dan Dorsa, Ph.D., OHSU vice president for research. The breakthroughs reflected in these numbers have added to OHSUs intellectual capital, which is the foundation for commercial licensing opportunities and biomedical startup companies and, ultimately, the development of new medical therapies, pharmaceuticals and devices.

J. Timothy Stout, M.D., Ph.D., M.B.A., OHSU vice president for commercialization strategies, added: The achievements in the last fiscal year make it clear that OHSU is well poised to take its commer
'/>"/>

Contact: Harry Lenhart
lenharth@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Lack of enzyme turns fat cells into fat burners
2. Programmable cells: Engineer turns bacteria into living computers
3. Gene therapy turns off mutation linked to Parkinsons disease
4. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
5. Jefferson researchers uncover new way nature turns genes on and off
6. Leukemia drug turns mini-molecules up, cancer genes down
7. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
8. Why were the HIV prevention trials in commercial sex workers abandoned?
9. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
10. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
11. Commercial fishing causes dangerous fluctuations in fish populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the fourth quarter and ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-455-2260 ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... malaria parasites form mutations that make them stubbornly resistant ... new treatments for a disease that afflicts more than ... disease models using yeast and successfully introduced five mutations ... The study, featured as the cover story of the ...
... consequences for humans and most animals but not Australia's ... The University of Queensland has found that unlike most ... starvation, the green-striped burrowing frog is able to absorb ... food, than frogs that had eaten regularly. , "They ...
... community over the evolution of the Great White shark, and ... Wright State University Lake Campus, is right in the middle ... one of the most feared predators of the sea, evolved ... rests with the mako shark. , "Most scientists would probably ...
Cached Biology News:Molecular models advance the fight against malaria 2A frog's life is food for thought 2A frog's life is food for thought 3Great White shark evolution debate involves WSU Lake Campus geology professor 2
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in the healthcare, life science ... US-based company Nano-C, their development and launch of promising ... photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... growing OPV sector. Novel derivatives: highly stable, ...
(Date:8/3/2015)... 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... life-threatening diseases, today announced that it will host its ... on Thursday, August 13, 2015 at 4:30 p.m. Eastern ... the release of fiscal 2016 first quarter results.  A ... two hours after the call at the Investor Relations ...
(Date:8/3/2015)... GERMANTOWN, Md. , Aug. 3, 2015   ... it will release first half and second quarter 2015 ... 10 th , 2015.  The Company will host a ... results and provide a general business update. ... (Domestic US) and 1-412-902-4262 (International), and asking to join ...
(Date:8/3/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a ... autologous cell therapies, announced today that RepliCel,s CEO, David ... in Minneapolis, Minnesota on August 5 ... highlight RepliCel,s 18-month milestones including CE Mark for its RCI-02 ... clinical data from both RCT-01 (tendon) and RCS-01 (skin) clinical ...
Breaking Biology Technology:Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2
... 19, 2012  Nautilus Neurosciences announced today that their ... subsidiary of Stellar Pharmaceuticals, was granted a Notice ... CAMBIA® (diclofenac potassium for oral solution) in the ... in adults. CAMBIA® is expected to be launched ...
... Cancer Research Centre (CNIO) routinely runs such tests on samples ... just the first step towards a truly personalised medicine. And ... in each organism at a molecular scale: the genes that ... antibodies circulating through the bloodstream; and the length of the ...
... of yoghurt have a note telling you that the product ... the spatial arrangement of their atoms. The two"isomers", L(+) and ... light to the right or left respectively. Of course the ... is not confined to solutions of yoghurt. Light interacts in ...
Cached Biology Technology:Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine 2Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine 3CNIO researchers take part in the most comprehensive personalized medicine study performed to date 2CNIO researchers take part in the most comprehensive personalized medicine study performed to date 3Designer lights from the physics lab 2
Agarose, Biotechnology grade, 500g...
AM100 is an aqueous-based, permanent mounting media designed for use with alkaline phosphatase and immunoperoxidase stained tissue sections....
... The c-Jun proto-oncogene was first identified as ... v-jun oncogene. Jun B and Jun D have ... in their C-terminal regions, which are involved in ... which are involved in transcriptional activation, diverge. ...
...
Biology Products: